Delayed presentation of ventricular septal defect (VSD) is common in developing countries. Such patients often have severe pulmonary arterial hypertension (PAH), which increases post-operative morbidity and mortality. To address these problems, we used our technique of unidirectional valved patch (UVP) for closure of VSD. Between January 2006 and December 2010, 17 patients (age 2-23 years, median 9 years) with a large VSD and severe PAH underwent VSD closure with UVP. Pre-operative mean indexed pulmonary vascular resistance (PVRI) was 10.9 ± 2.2 Wood units and mean pre-operative systemic saturation was 93.4 ± 2.6%. Shunt was bidirectional in 15 patients and predominantly right to left in two. After VSD closure, intra-operative transoesophageal echocardiography revealed a right to left shunt across the patch in three patients 2, 7 and 9 years of age who had pre-operative PVRI of 9.5, 9.8 and 11.1 Wood units, respectively. There were no in-hospital deaths and all patients had uneventful recovery. Mean follow-up was 30 ± 14.7 months and all patients are well without cyanosis. Echocardiography showed no shunt across the patch and all have systemic saturation >95%. We conclude that UVP is a promising technique in patients with large VSD and severe PAH.
INTRODUCTION
In contrast to developed countries, delayed presentation and diagnosis of ventricular septal defect (VSD) is not uncommon in developing countries; therefore, early and late results are affected by development of pulmonary arterial hypertension (PAH) [1, 2] . These patients may require advanced pharmacological agents or even extra-corporeal membrane oxygenation (ECMO) in early post-operative phase, but these are either unavailable or are too expensive [3, 4] . Surgical alternatives include leaving an inter-atrial communication or performing VSD closure with a fenestrated VSD patch or a unidirectional valved patch (UVP) [3] [4] [5] [6] [7] [8] . In an earlier publication [5] , we described our own technique of VSD closure, using a UVP. As our experience has grown with increasing follow-up, we are now in a position to present more detailed early-and mid-term results, using this technique.
PATIENTS AND METHODS
Between January 2006 and December 2010, 17 patients (Table 1) with VSD and basal indexed pulmonary vascular resistance (PVRI) of >8 Wood units underwent VSD closure with a fenestrated UVP. Hospital records of these patients were analysed in this retrospective study. Study protocol was approved by the institute Ethics committee with waiver of individual patient consent. Pre-operative data consisted of clinical history, physical examination, chest X-ray, electrocardiography, echocardiography and cardiac catheterization with complete haemodynamic data and oximetry at rest and following administration of high-flow oxygen.
Out of 17 patients, 12 were male. None had Down's syndrome. Mean age was 9.2 ± 5.4 years (range, 2-23 years, median 9 years). Mean weight was 22 kg (median 15 kg, range, 8-45 kg). Recurrent respiratory tract infection and tachypnoea were chief complaints. Fifteen out of 17 were in NYHA class-III. None had cyanosis or haemoptysis. Chest X-ray revealed mild cardiomegaly in 5 patients and no cardiomegaly in 12 patients with signs of severe PAH. Echocardiography revealed a predominant right to left shunt in 2 patients and bidirectional shunt in remaining 15. A peri-membranous VSD was visualized in 15 patients. One patient had one peri-membranous and one additional muscular VSD. Another patient had two muscular VSDs. Four patients each had an associated ostium secundum atrial septal defect, and a patient ductus arteriosus, which were simultaneously repaired.
Pre-operative mean PVRI was 10.9 ± 2.2 Wood units (range, 8.7-16.1, median 10.6 Wood units). Following oxygen administration, PVRI decreased in all patients with an increase in left to right shunt. Mean PVRI following oxygen inhalation was 3.72 ± 1.98 Wood units (range, 1.3-9.8, median 4.2 Wood units). Mean systemic saturation on room air was 93.4 ± 2.6% (range, 87-97%, median 94%). Mean pulmonary artery systolic pressure was 94.4 ± 11.6 mmHg (75-110 mmHg, median 92 mmHg), and diastolic pressures were 45.6 ± 11.3 mmHg (23-67 mmHg, median 45 mmHg) with a mean pulmonary-to-systemic-blood-flow ratio of 1.38 ± 0.25 (1.1-1.8, median 1.4).
Decision to perform surgery was made by the surgeon and cardiologist following informed consent and acceptance of risk by the patient's family. Intra-operative transoesophageal echocardiography was performed after induction of anaesthesia and VSD was assessed. All patients were operated under standard cardiopulmonary bypass (CPB). Phenoxybenxamine (1 mg/kg) was administered at the time of aortic cannulation. After opening the right atrium, the UVP was constructed with a single piece of Dacron patch [5, 6] (Fig. 1) . The width of the patch was almost the same as the size of the VSD, and the length of the patch was one and a half times the length of VSD. A 4-mm fenestration was made in the patch slightly off centre using a 4-mm aortic punch. The patch was then folded upon itself in such a way that after it was folded, the dimensions were adequate for VSD closure. The flap created by the folding of the patch covered the fenestration. The patch was sutured to the edges of the VSD using interrupted or continuous sutures in such a way that the flap lies towards the left ventricular side and its free edge was directed towards the left ventricular apex. No inter-atrial communication was left. All patients received dopamine (5-10 µg/kg/min), nitroglycerine or nitroprusside (0.5-2 µg/ kg/min) or milrinone prior to weaning from CPB. In the last 10 patients, sildenafil (0.5 mg/kg) was started after arrival in the intensive care unit (ICU) through the nasogastric tube. Following extubation, oral angiotensin converting enzyme inhibitors or phenoxybenxamine and sildenafil were administered and inotropes were weaned off. Post-operative transthoracic echocardiography was used to assess the degree of shunting across the patch. All patients were followed up at 1, 3, 6 months and yearly thereafter. Follow-up consisted of regular clinical examination, pulse oximetry to measure oxygen saturation and echocardiography at regular intervals. Detailed cardiac catheterization is planned in a follow-up study.
STATISTICAL ANALYSIS
All pre-operative and post-operative data are reported as range and mean ± standard deviation. Median values are also reported. 
RESULTS
All patients were uneventfully weaned off CPB. Mean aortic cross-clamp time was 32.2 ± 5.7 min (27-45 min, median 30 min) and mean CPB time was 52.2 ± 11.4 min (40-87 min, median 50 min).
Mean systemic saturation at the time of termination of CPB was 93.3 ± 4.3% (range, 84-100%, median 93%). Three out of 17 had a right to left shunt intra-operatively on transoesophageal echocardiography and they had episodes of systemic desaturation after termination of CPB and in the ICU. As described in Table 1 , these patients were 2 years (Patient ID 13), 7 years (Patient ID 2) and 9 years (Patient ID 15) of age who had a preoperative PVRI of 9.5, 9.8 and 11.1 Wood units, respectively. None of the patients required nitric oxide or ECMO support. There were no early deaths. Mean duration of mechanical ventilation was only 7.6 ± 2.7 h (range, 5-16 h, median 7 h). The mean systemic saturation in ICU was 96.3 ± 4% (87-100%, median 98%). The same three patients (18%) had episodes of systemic desaturation in the ICU, the lowest saturation being 87%. These were documented as being due to a right to left shunt through the UVP on transthoracic echocardiography. These were managed by supplemental oxygen without the need for re-instituting mechanical ventilation. The inotropes could be weaned off on first post-operative day in all patients. Mean ICU stay was 1.9 ± 0.3 days (1-3 days, median 2 days). Mean hospital stay was 5.1 ± 1.3 days (median 5 days, range, 4-10 days).
There were no late deaths. Mean follow-up was 30 ± 14.7 months (range, 4-51 months). All patients were in NYHA class-I up except one 23-year old male patient (Patient ID 5 in Table 1 ) who was NYHA class-II. No patient reported cyanosis or required re-intervention.
DISCUSSION
Previous reports have shown that results after closure of a large VSD with PAH are dependent upon the Heath-Edwards classification at the time of closure [1] . VSD closure in children with elevation in PVR preoperatively that decreases after closure of the defect has been described [2, 9] . Kanan et al. [9] recommended VSD closure in such patients. Castaneda et al. [2] reviewed 55 such patients and found that at 1 year after surgery, the PVR fell but remained above normal in most patients. Hallidie-Smith et al. [10] reported 36 patients with VSD and PVR of at least 8 Wood units. Twenty-eight of the 36 patients survived after VSD closure. At cardiac catheterization, 18 of 25 patients had normal to moderately elevated pulmonary artery pressure, and 9 had PVR of 3 Wood units or less. Recent reports in patients with primary PAH who have improved haemodynamics with decreased pulmonary pressures and improved exercise capacity following administration of high-dose calcium channel blocker verapamil [11] and phosphodiesterase inhibitors and prostacyclin [12] suggest that pulmonary vascular remodelling may take place in children. This seems to make VSD closure an attractive option even with elevated PVRI.
Mortality and morbidity for patients with VSD and PAH have been high in the past and even in the present era [2, 6] . Following CPB and later following administration of protamine, vasoactive substances such as thromboxane A2 and catecholamines are released, which aggravate PAH and respiratory failure, which may be the cause of death in these patients [13] .
Multiple surgical strategies have been described to manage such patients. One is prior pulmonary arterial banding [14] but it carries high morbidity and is always associated with a need for a later definitive surgery and its potential complications. Most surgeons leave an inter-atrial communication to decompress the right atrium and right ventricle during pulmonary hypertensive crisis. However, shunting across this communication is often unreliable with the potential for a left to right shunt when the pulmonary arterial pressures decrease. Another approach is a fenestrated VSD patch that converts a large VSD into a small VSD. The fenestration allows for a right to left shunt in the case of pulmonary hypertensive crisis. With sustained PAH, the fenestration would allow for a right to left shunt as in case of UVP but once the pulmonary artery pressures decrease it has the potential for left to right shunt with associated complications such as infective endocarditis and systemic embolism and need for subsequent surgical or interventional closure [4] . A UVP has been described for closure of large VSDs with borderline operability [4] [5] [6] [7] [8] . The patch is designed to function like a flap mechanism with unidirectional opening that allows a right to left shunt during an episode of pulmonary hypertensive crisis but closes and does not allow a left to right shunt once the pulmonary artery pressures come down. Thus, it prevents acute right ventricular failure and death from refractory pulmonary hypertension.
The UVP was first described by Zhou et al. [8] . They used a Dacron patch with a fenestration 0.5-1 cm slightly off centre with pericardium attached to three sides of the Dacron patch. Novick et al. [3, 4] reported their technique in 1998 and followed it up with their experience with the same technique in 2005. Another modification was proposed by Zhang et al. [8] who used an aortic homograft with attached anterior mitral leaflet to construct the UVP. All techniques described above suffer from the limitation that they are often time-consuming. The sizing may be inaccurate, and fenestration may be misplaced if the patch is constructed before inspection of the defect. When the patch is constructed after cardioplegic arrest, it adds to the cardioplegia time. To minimize this, we devised an innovative way of constructing the UVP [5] that takes <30 s. The median ischaemic time was 30 min and median CPB time was 50 min in our patients, which is fairly close to the routine ischaemic and CPB times for an isolated VSD closure.
Results with UVP have been gratifying. It is difficult to compare the results of various techniques as patient populations are heterogeneous and the number of patients is small. In our study, none of the patient had any complication with UVP and all patients could be extubated uneventfully with a median time to extubation 7 h. Median ICU stay was 2 days and median hospital stay was 5 days, which is comparable to our other routine patients. No patient developed any significant complication after surgery. At follow-up, most of the patients were in NYHA class-I and were off medications. None required any re-intervention. There was no death. This technique of UVP is safe, effective and easily reproducible in our experience.
Long-term survival in patients with severely elevated pulmonary vascular resistance and pulmonary artery pressures is controversial as discussed above and it is not possible to conclusively prove that a UVP actually decreases the mortality and morbidity, unless there are prospective randomized trials with pre-operative and post-operative resting and exercise oximetry with demonstration of direction of shunt by echocardiography and quantification of shunt in immediate and late post-operative period. It is however difficult to justify these trials for ethical reasons. One of CONGENITAL S. Talwar et al. / Interactive CardioVascular and Thoracic Surgerythe limitations of our study is the lack of availability of long-term echocardiographic and cardiac catheterization data. We expect to shortly provide more data in this direction. Our findings are in sharp contrast to a recent study from China [15] in which 876 patients with VSD and PAH underwent VSD closure. In 195 of these, a UVP was used to close the VSD. The authors performed a multiple logistic regression analysis with propensity score matching, and found that in the 138 propensity-matched pairs, there were no significant differences in early and late survival. Whether these findings hold true for our patient population will be known only after more follow-up of our patients.
CONCLUSION
UVP for closure of VSD helps in tidying over immediate postoperative period in patients with borderline operability. Earlyand mid-term results of this technique are promising but long-term results are awaited. The use of UVP in patients with established Eisenmenger's syndrome needs further evaluation.
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